Clinical Trials Logo

Lipodystrophy clinical trials

View clinical trials related to Lipodystrophy.

Filter by:

NCT ID: NCT03059121 Recruiting - HIV Clinical Trials

The Cleveland Cardiometabolic Cohort

Start date: September 2016
Phase:
Study type: Observational

In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

NCT ID: NCT02325674 Recruiting - Clinical trials for Partial Lipodystrophy

MEASuRE: Metreleptin Effectiveness And Safety Registry

MEASuRE
Start date: January 15, 2016
Phase:
Study type: Observational [Patient Registry]

The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.

NCT ID: NCT02262832 Recruiting - Diabetes Clinical Trials

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

Start date: October 9, 2014
Phase: Phase 3
Study type: Interventional

Background: - Generalized lipodystrophy can cause high blood fat levels and resistance to insulin. This can lead to health problems including diabetes. Researchers have found that the drug metreleptin improves health in people with this disease. Objective: - To test the safety and effectiveness of metreleptin. Eligibility: - People ages 6 months and older with generalized lipodystrophy who: - have received metreleptin through NIH studies AND - cannot get it through approved or compassionate use mechanisms in their home country. Design: - Participants will come to NIH approximately every 6 months during year one, then every 1 2 years. Financial assistance may be available for travel within the U.S. - At visits, participants will get a supply of metreleptin to take home for daily injections. They will have: - plastic catheter placed in an arm vein. - blood tests, urine collection, and physical exam. - oral glucose tolerance test, drinking a sweet liquid. - ultrasound of the heart, liver, uterus, and ovaries. A gel and a probe are placed on the skin and pictures are taken of the organs. - echocardiogram, which takes pictures of the heart with sound waves. - Resting Metabolic Rate taken. A plastic hood is worn over the head while the oxygen they breathe is measured. - Participants will have up to 3 DEXA scan x-rays per year. - Participants may have: - annual bone x-rays. - liver biopsies every few years. A needle will be inserted into the liver to obtain a small piece. Participants will sign a separate consent for this. - Participants must be seen regularly by their local doctors and have blood tests at least every 3 6 months at home.

NCT ID: NCT01093950 Recruiting - Lipodystrophy Clinical Trials

White Light Scanning to Aid Body Contouring: A Pilot Project

Start date: January 2005
Phase: N/A
Study type: Observational

A white light scanner can more accurately measure body contouring subjects than standard anthropomorphic methods.

NCT ID: NCT00910936 Recruiting - HIV Infections Clinical Trials

Exercise for Patients With HIV Infections

Start date: May 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators will evaluate the effects of an endurance exercise program on the physical performance, the well being, and indicators of metabolic function in patients with an HIV infection.

NCT ID: NCT00426296 Recruiting - HIV Infections Clinical Trials

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Start date: August 2006
Phase: Phase 4
Study type: Interventional

SHARE: Simple HAART with Abacavir, Reyataz, and Epivir

NCT ID: NCT00172315 Recruiting - Clinical trials for Acquired Immunodeficiency Syndrome

Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects

Start date: December 2003
Phase: Phase 3
Study type: Observational

Magnetic resonance spectroscopy (MRS) is commonly applied in medicine with 1H proton or 31-phosphorus spectra. The proton MRS is often used in evaluating the central nervous system and 31P MRS is used in muscular diseases or neoplasms. However, the proton MRS is also considered to be applied to the musculoskeletal system because of its profound amount of protons. Ballon used the STEAM technique, and Schick used the PRESS technique, to investigate the lipid and water spectra of the bone marrow and also correlated those with hematological diseases and post-treatment effects. Schellinger et al. used the STEAM sequence to calculate the lipid content of the vertebral bone marrow and found that it was influenced according to age and sex. The investigator had used the proton MRS to evaluate the lipid and water spectra of the femoral head and revealed its significance in predicting avascular necrosis of the femoral head. According to the above research literature, the investigators considered further investigation of the proton MRS in evaluating the musculoskeletal system.